Archive for the ‘
Legal actions ’ Category
Wednesday, July 22nd, 2009
Although advertising and marketing dollars among cost-conscious hospital clientele are spent more slowly and inconsistently, the Massachusetts-based brand communications agency PARTNERS+simons advises these clients to think more like marketers. With other priorities, healthcare reform, and healthcare-cost concerns at the top of the list, hospital clients seldom place an importance on ...
Posted in
Economy, Legal actions, Technology, Uncategorized |
No Comments »
Tuesday, July 21st, 2009
Many Americans do not feel that access to health coverage will result in access to actual medical care and are willing to adopt new models of care, which may have the potential to expand access without increasing costs. A PricewaterhouseCoopers study titled, “Jammed Access: Widening the Front Door to Healthcare” ...
Posted in
Economy, Legal actions, Technology, Uncategorized |
No Comments »
Tuesday, July 14th, 2009
Sermo claims that its break with the American Medical Association was driven by physicians' need for an alternative voice on critical healthcare issues by way of radical transparency. The AMA believes the value no longer warranted further participation and opted not to renew with Sermo in May. At the result ...
Posted in
Economy, Legal actions, Magazine production, R&D Directions, Technology, e-Marketing |
1 Comment »
Thursday, July 9th, 2009
A Web-based, Pri-Med issued poll that was e-mailed to more than 112,585 Pri-Med alumni clinicians nationwide has highlighted several interesting perspectives on healthcare reform. The poll, which was fielded from June 4 to June 11, garnered a sample of 204 clinicians. Recent poll results among these U.S. clinicians have revealed ...
Posted in
Economy, Legal actions |
No Comments »
Monday, June 29th, 2009
Since Med Ad News' diabetes therapeutic feature was published last month, questions regarding the safety of insulin analogues such as the insulin glargine Lantus have surfaced. Now diabetes drug marketers Sanofi-Aventis SA and Novo Nordisk AS are engaged in rapid-fire PR initiatives to back the clinical evidence of their products.
On ...
Posted in
Adwise, DTC advertising, Legal actions, Magazine production, Patient education, Professional education, R&D Directions, e-Marketing |
No Comments »
Tuesday, June 23rd, 2009
Prevention may never overthrow treatment, but healthcare-focused companies and their advertising agencies are mindful of the wellness trend. Public opinion favors prevention as the most important healthcare reform priority, and Americans overwhelmingly support increasing funding for prevention programs to reduce disease and keep people healthy. Now, healthcare-focused marketing and advertising ...
Posted in
DTC advertising, Economy, Legal actions, Magazine production, Patient education, Technology, e-Marketing |
No Comments »
Tuesday, June 16th, 2009
Med Ad News’ interest in pharmaceutical advertising agencies’ philanthropic activities has grown since creating the Heart Award in 2009. Juice Pharma Worldwide reached out to share their recent project-oriented philanthropic involvement with Little Flower Children and Family Services of New York and additional pro-bono advertising plans for the future.
In May, ...
Posted in
Adwise, DTC advertising, Legal actions, Magazine production, Manny Awards, Med Ad News, Pro bono, e-Marketing |
No Comments »
Wednesday, May 13th, 2009
This was a not-so-pleasant surprise to find first thing Tuesday morning: an EU court ruled that media comment on medicines may constitute advertising. The case involves Danish journalist Frede Damgaard, who wrote back in 2003 on his Website about a natural supplement called Hyben Total, which was initially licensed for ...
Posted in
Legal actions, Uncategorized |
No Comments »
Tuesday, April 7th, 2009
FDA has cracked down on sponsored links that show up on Google and other search engines on behalf of 14 different pharmaceutical companies: Bayer AG, Biogen Idec Inc., Boehringer Ingelheim Pharmaceuticals Inc., Cephalon Inc., Forest Laboratories Inc., Genentech Inc., GlaxoSmithKline, Johnson & Johnson, Eli Lilly and Co., Merck & Co., ...
Posted in
DTC advertising, Legal actions, Patient education, Sales & Marketing |
2 Comments »
Wednesday, March 4th, 2009
With the pharmaceutical industry's effort to enshrine federal FDA pre-emption in the laws of the land taking a tumble after today's Supreme Court ruling in Wyeth v. Levine, mass torts plaintiffs attorneys everywhere are licking their lips. We asked Will Sachse, a partner in the antitrust/competition and mass torts and ...
Posted in
Legal actions |
2 Comments »
|
|
